- Home
- HUIZ vs SRZN Comparison
HUIZ vs SRZN Comparison
Compare HUIZ & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUIZ
- SRZN
- Stock Information
- Founded
- HUIZ 2006
- SRZN 2015
- Country
- HUIZ China
- SRZN United States
- Employees
- HUIZ N/A
- SRZN N/A
- Industry
- HUIZ Specialty Insurers
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- HUIZ Finance
- SRZN Health Care
- Exchange
- HUIZ Nasdaq
- SRZN Nasdaq
- Market Cap
- HUIZ 36.6M
- SRZN 36.1M
- IPO Year
- HUIZ 2020
- SRZN N/A
- Fundamental
- Price
- HUIZ $3.52
- SRZN $11.93
- Analyst Decision
- HUIZ
- SRZN Strong Buy
- Analyst Count
- HUIZ 0
- SRZN 2
- Target Price
- HUIZ N/A
- SRZN $38.50
- AVG Volume (30 Days)
- HUIZ 30.2K
- SRZN 16.3K
- Earning Date
- HUIZ 03-19-2025
- SRZN 05-07-2025
- Dividend Yield
- HUIZ N/A
- SRZN N/A
- EPS Growth
- HUIZ N/A
- SRZN N/A
- EPS
- HUIZ 0.29
- SRZN N/A
- Revenue
- HUIZ $170,927,079.00
- SRZN $10,000,000.00
- Revenue This Year
- HUIZ N/A
- SRZN N/A
- Revenue Next Year
- HUIZ $10.46
- SRZN N/A
- P/E Ratio
- HUIZ $12.24
- SRZN N/A
- Revenue Growth
- HUIZ N/A
- SRZN N/A
- 52 Week Low
- HUIZ $2.15
- SRZN $6.00
- 52 Week High
- HUIZ $10.58
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- HUIZ 54.40
- SRZN 54.85
- Support Level
- HUIZ $3.36
- SRZN $10.65
- Resistance Level
- HUIZ $3.65
- SRZN $11.95
- Average True Range (ATR)
- HUIZ 0.39
- SRZN 0.81
- MACD
- HUIZ 0.01
- SRZN 0.08
- Stochastic Oscillator
- HUIZ 42.00
- SRZN 72.36
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).